目次

Table of Contents

1. Executive Summary

2. Blood Cancer Drugs Market Characteristics

3. Blood Cancer Drugs Market Trends And Strategies

4. Blood Cancer Drugs Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Blood Cancer Drugs Market Size and Growth
5.1. Global Blood Cancer Drugs Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Blood Cancer Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Blood Cancer Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Blood Cancer Drugs Market Segmentation
6.1. Global Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Leukemia
Lymphoma
6.2. Global Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Rituxan or Mabthera (Rituximab)
Gleevec or Glivec (Imatinib)
Revlimid (Lenalidomide)
Velcade (Bortezomib)
Tasigna (Nilotinib)
Pomalyst (Pomalidomide)
Vidaza (Azacitidine)
Kyprolis (Carfilzomib)
Adcetris (Brentuximab Vedotin)
Other Drugs
6.3. Global Blood Cancer Drugs Market, Segmentation By Treatment Approaches, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Key Findings
Chemotherapeutic
mAbs or Targeted Therapies
Immunotherapeutic

7. Blood Cancer Drugs Market Regional And Country Analysis
7.1. Global Blood Cancer Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Blood Cancer Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Blood Cancer Drugs Market
8.1. Asia-Pacific Blood Cancer Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Blood Cancer Drugs Market, Segmentation By Treatment Approaches, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Blood Cancer Drugs Market
9.1. China Blood Cancer Drugs Market Overview
9.2. China Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Blood Cancer Drugs Market, Segmentation By Treatment Approaches, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Blood Cancer Drugs Market
10.1. India Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Blood Cancer Drugs Market, Segmentation By Treatment Approaches, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Blood Cancer Drugs Market
11.1. Japan Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.2. Japan Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Blood Cancer Drugs Market, Segmentation By Treatment Approaches, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Blood Cancer Drugs Market
12.1. Australia Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Blood Cancer Drugs Market, Segmentation By Treatment Approaches, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Blood Cancer Drugs Market
13.1. Indonesia Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Blood Cancer Drugs Market, Segmentation By Treatment Approaches, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Blood Cancer Drugs Market
14.1. South Korea Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.2. South Korea Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Blood Cancer Drugs Market, Segmentation By Treatment Approaches, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Blood Cancer Drugs Market
15.1. Western Europe Blood Cancer Drugs Market Overview
15.2. Western Europe Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Blood Cancer Drugs Market, Segmentation By Treatment Approaches, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Blood Cancer Drugs Market
16.1. UK Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Blood Cancer Drugs Market, Segmentation By Treatment Approaches, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Blood Cancer Drugs Market
17.1. Germany Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Blood Cancer Drugs Market, Segmentation By Treatment Approaches, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Blood Cancer Drugs Market
18.5. France Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.6. France Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.7. France Blood Cancer Drugs Market, Segmentation By Treatment Approaches, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Blood Cancer Drugs Market
19.9. Italy Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Blood Cancer Drugs Market, Segmentation By Treatment Approaches, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Blood Cancer Drugs Market
20.13. Spain Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Blood Cancer Drugs Market, Segmentation By Treatment Approaches, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Blood Cancer Drugs Market
21.1. Eastern Europe Blood Cancer Drugs Market Overview
21.2. Eastern Europe Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Blood Cancer Drugs Market, Segmentation By Treatment Approaches, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Blood Cancer Drugs Market
22.1. Russia Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Blood Cancer Drugs Market, Segmentation By Treatment Approaches, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Blood Cancer Drugs Market
23.1. North America Blood Cancer Drugs Market Overview
23.2. North America Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Blood Cancer Drugs Market, Segmentation By Treatment Approaches, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Blood Cancer Drugs Market
24.1. USA Blood Cancer Drugs Market Overview
24.2. USA Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Blood Cancer Drugs Market, Segmentation By Treatment Approaches, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Blood Cancer Drugs Market
25.1. Canada Blood Cancer Drugs Market Overview
25.2. Canada Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Blood Cancer Drugs Market, Segmentation By Treatment Approaches, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Blood Cancer Drugs Market
26.1. South America Blood Cancer Drugs Market Overview
26.2. South America Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Blood Cancer Drugs Market, Segmentation By Treatment Approaches, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Blood Cancer Drugs Market
27.1. Brazil Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Blood Cancer Drugs Market, Segmentation By Treatment Approaches, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Blood Cancer Drugs Market
28.1. Middle East Blood Cancer Drugs Market Overview
28.2. Middle East Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Blood Cancer Drugs Market, Segmentation By Treatment Approaches, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Blood Cancer Drugs Market
29.1. Africa Blood Cancer Drugs Market Overview
29.2. Africa Blood Cancer Drugs Market, Segmentation By Blood Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Blood Cancer Drugs Market, Segmentation By Treatment Approaches, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Blood Cancer Drugs Market Competitive Landscape And Company Profiles
30.1. Blood Cancer Drugs Market Competitive Landscape
30.2. Blood Cancer Drugs Market Company Profiles
30.2.1. Amgen Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. AstraZeneca plc.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Bayer AG
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Eli Lilly and Company Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Johnson & Johnson
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance

31. Global Blood Cancer Drugs Market Competitive Benchmarking

32. Global Blood Cancer Drugs Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Blood Cancer Drugs Market

34. Blood Cancer Drugs Market Future Outlook and Potential Analysis
34.1 Blood Cancer Drugs Market In 2028 - Countries Offering Most New Opportunities
34.2 Blood Cancer Drugs Market In 2028 - Segments Offering Most New Opportunities
34.3 Blood Cancer Drugs Market In 2028 - Growth Strategies
34.3.1 Market Trend Based Strategies
34.3.2 Competitor Strategies

35. Appendix
35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer